CL2020001392A1 - Composiciones para uso en la reducción de la nocicepción en infantes y niños pequeños. - Google Patents

Composiciones para uso en la reducción de la nocicepción en infantes y niños pequeños.

Info

Publication number
CL2020001392A1
CL2020001392A1 CL2020001392A CL2020001392A CL2020001392A1 CL 2020001392 A1 CL2020001392 A1 CL 2020001392A1 CL 2020001392 A CL2020001392 A CL 2020001392A CL 2020001392 A CL2020001392 A CL 2020001392A CL 2020001392 A1 CL2020001392 A1 CL 2020001392A1
Authority
CL
Chile
Prior art keywords
compositions
infants
nociception
young children
reduction
Prior art date
Application number
CL2020001392A
Other languages
English (en)
Inventor
Norbert Sprenger
Sami Damak
Francis Foata
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of CL2020001392A1 publication Critical patent/CL2020001392A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Pediatric Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dairy Products (AREA)

Abstract

La presente invención describe composiciones que comprenden 6’-sialilactosa (6’SL) y lacto-N-tetraosa (LNT), para uso en la reducción de la nocicepción en un infante o en un niño pequeño. Las composiciones son, en particular, útiles para reducir el dolor abdominal y, consecuentemente también contribuyen a reducir los períodos de llanto y a mejorar la calidad del sueño y la calidad de vida general de los infantes y niños pequeños.
CL2020001392A 2017-12-22 2020-05-27 Composiciones para uso en la reducción de la nocicepción en infantes y niños pequeños. CL2020001392A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP17209905 2017-12-22

Publications (1)

Publication Number Publication Date
CL2020001392A1 true CL2020001392A1 (es) 2020-10-02

Family

ID=60888219

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2020001392A CL2020001392A1 (es) 2017-12-22 2020-05-27 Composiciones para uso en la reducción de la nocicepción en infantes y niños pequeños.

Country Status (8)

Country Link
US (2) US11357785B2 (es)
EP (1) EP3727038A1 (es)
CN (1) CN111432661A (es)
AU (1) AU2018390181A1 (es)
CL (1) CL2020001392A1 (es)
MX (1) MX2020007197A (es)
PH (1) PH12020550959A1 (es)
WO (1) WO2019121929A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2924137T3 (es) * 2016-05-05 2022-10-04 Glycom As Composición que comprende HMOS para uso en el tratamiento de la hipersensibilidad y/o dolor visceral mediados por mastocitos
US20220079963A1 (en) 2018-12-21 2022-03-17 Societe Des Produits Nestle S.A. A nutritional composition comprising 2'-fucosyllactose (2' fl) to improve the gastrointestinal barrier
WO2020128948A1 (en) * 2018-12-21 2020-06-25 Glycom A/S Composition and method for promoting intestinal barrier healing
WO2020126542A1 (en) * 2018-12-21 2020-06-25 Societe Des Produits Nestle S.A. A nutritional composition comprising 6'sl and lnt in combination to improve the gastrointestinal barrier function
CN113924101A (zh) * 2019-04-09 2022-01-11 因特因思克医药物公司 用于治疗疼痛的免疫调节寡糖
WO2020250185A1 (en) * 2019-06-12 2020-12-17 Glycom A/S Human milk oligosaccharides and compositions thereof for use in preventing, managing or treating symptoms related to migraine
EP4068992A1 (en) * 2019-12-06 2022-10-12 Société des Produits Nestlé S.A. Compositions for use in the reduction of pain and/or perception of pain in infants and young children
CN114786501A (zh) * 2019-12-11 2022-07-22 雀巢产品有限公司 用于减少婴儿和幼儿的伤害感觉和/或其他健康益处的组合物
WO2021231751A1 (en) 2020-05-13 2021-11-18 Glycosyn LLC Fucosylated oligosaccharides for prevention of coronavirus infection
US11324766B2 (en) 2020-05-13 2022-05-10 Glycosyn LLC 2'-fucosyllactose for the prevention and treatment of coronavirus-induced inflammation
CN116391026A (zh) * 2020-06-26 2023-07-04 雀巢产品有限公司 产生丝氨酸蛋白酶抑制剂
EP4255220A1 (en) * 2020-12-01 2023-10-11 FrieslandCampina Nederland B.V. 2'-fucosyllactose for use in stimulating f. prausnitzii abundance
US20240000122A1 (en) * 2020-12-04 2024-01-04 Societe Des Produits Nestle S.A. Compositions comprising human milk oligosaccharides for use in a subject to support night sleep duration
WO2022118270A1 (en) * 2020-12-04 2022-06-09 Glycom A/S Human milk oligosaccharides for use in supporting night sleep duration
EP4313064A1 (en) * 2021-03-22 2024-02-07 Société des Produits Nestlé S.A. Human milk oligosaccharides

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5180674A (en) 1990-04-16 1993-01-19 The Trustees Of The University Of Pennsylvania Saccharide compositions, methods and apparatus for their synthesis
US5545553A (en) 1994-09-26 1996-08-13 The Rockefeller University Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
RU2433751C2 (ru) 2009-05-05 2011-11-20 Александр Владимирович Диковский Композиция для нормализации микрофлоры и очищения организма от токсинов и способ оздоровления организма
EP2454948A1 (en) * 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula
EP3074020B1 (en) * 2013-11-15 2022-03-30 Société des Produits Nestlé S.A. Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants and young children
US20160243139A1 (en) 2014-10-29 2016-08-25 Glycom A/S Composition comprising HMSs/HMOs and use thereof
JP7182872B2 (ja) * 2014-10-29 2022-12-05 グリコム・アクティーゼルスカブ 過敏性腸症候群の治療のための合成組成物および方法
ES2947458T3 (es) * 2015-03-05 2023-08-09 Nestle Sa Composiciones para su uso en la prevención o el tratamiento de infecciones gastrointestinales en lactantes o niños pequeños
AU2016227597B2 (en) 2015-03-05 2020-01-16 Société des Produits Nestlé S.A. Compositions for use in improving stool consistency or frequency in infants or young children
US11957148B2 (en) * 2015-12-15 2024-04-16 Societe Des Produits Nestle S.A. Mixture of human milk oligosaccharides(HMOs)

Also Published As

Publication number Publication date
US11357785B2 (en) 2022-06-14
WO2019121929A1 (en) 2019-06-27
EP3727038A1 (en) 2020-10-28
BR112020010958A2 (pt) 2020-11-17
US20200330493A1 (en) 2020-10-22
PH12020550959A1 (en) 2021-04-26
AU2018390181A1 (en) 2020-05-28
RU2020123416A3 (es) 2022-04-08
US20220331347A1 (en) 2022-10-20
MX2020007197A (es) 2020-09-03
RU2020123416A (ru) 2022-01-18
CN111432661A (zh) 2020-07-17

Similar Documents

Publication Publication Date Title
CL2020001392A1 (es) Composiciones para uso en la reducción de la nocicepción en infantes y niños pequeños.
CL2018001825A1 (es) Composiciones que comprenden 2fl y lnnt para usar en infantes o niños pequeños para prevenir la obesidad en la vida posterior o comorbilidades relacionadas
CL2018001826A1 (es) Composiciones que comprenden 2fl y lnnt para controlar la ingesta de alimento y el crecimiento en infantes o niños pequeños
CL2019000132A1 (es) Composición lipídica para usar en infantes y niños pequeños para promover el confort del intestino y la óptima absorción de grasa y calcio.
PH12019550208A1 (en) Hmos blends for use in infants or young children for health purposes
PH12017550039A1 (en) Compositions for use in improving stool consistency or frequency in infants or young children
CL2017001001A1 (es) Derivados de carbazaol
PH12021551071A1 (en) A nutritional composition comprising 6`sl and lnt in combination to improve the gastrointestinal barrier function
CL2020001195A1 (es) Composiciones que comprenden al menos un oligosacárido n-acetilado y al menos uno fucosilado para usar en la promoción de la capacidad digestiva en infantes y niños pequeños.
PH12020550653A1 (en) Synthetic nutritional compositions tailored for infants of specific ages, and nutritional systems comprising them
PH12018500953A1 (en) Nutritional compositions and infant formulas to promote myelination in the brain
PH12018500924A1 (en) Nutritional compositions and infant formulas to promote myelination in the brain
Sailesh et al. Vestibular modulation of endocrine secretions—A review
PH12017500202A1 (en) Nutritional composition with low content of medium-chain fatty acids in specific proportions, and its uses
CL2018001595A1 (es) Composiciones nutricionales y fórmulas infantiles para promover la mielinización en el cerebro
BR112022008956A2 (pt) Composições para uso na redução de dor e/ou percepção de dor em bebês e crianças pequenas
BR112018067926A2 (pt) composições nutricionais e seus usos
MX2018006290A (es) Composiciones nutritivas y formulas infantiles para promover la mielinizacion en el cerebro.
CL2016000276A1 (es) Lactoferrina y memoria y velocidad de aprendizaje en niños
BR112017007362A2 (pt) composições nutricionais compreendendo sn-1(3)-monoacilgliceróis para uso no tratamento de atrasos de crescimento em bebês ou crianças
BR112015016465A2 (pt) uso de glutamina ou de uma composição; método não-medicinal para melhora posterior da função cognitiva em um bebê muito prematuro nascido pequeno para a idade gestacional; e método não-medicinal para melhora posterior do q.i em um bebê muito prematuro nascido pequeno para a idade gestacional
Morozova et al. Psychological aspects in the education of children in substitute families
Zakirov Comparative analysis of psychological development of children brought up in infant orphanages and in foster families
TH173011A (th) สูตรผสมที่ได้รับการหมักด้วยโอลิโกแซคคาไรด์ที่ไม่สามารถย่อยได้
LITKE DEVELOPMENT OF THE PERSON’S CREATIVE SKILLS IN MODERN SOCIETY